Live Breaking News & Updates on Group Acarbose Tablets Boshutai

Stay updated with breaking news from Group acarbose tablets boshutai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Uni-Bio Science Group Limited Announces 2022 Annual Results

<b> Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved </b> <br/> <b>Expanding Portfolio with New Drug Innovations and Strategic R&amp;D Partnerships </b><b/> <br/> <br/> HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – <b>Uni-Bio Science Group Limited</b> ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the "Year"). ....

Kingsley Leung , Dotbio Pte , China Center , Alliance Procurement , Bio Science Group Limited Uni , Bio Science Group , Cell Penetration Protein Alternation Technology Ce , China National Medical Products Administration , Group Acarbose Tablets Boshutai , Group Bogutai , Alephoson Biopharmaceuticals Ltd , Record High Turnover , High Turnover , Profit Achieved , New Drug Innovations , Strategic Rd Partnerships , Uni Bio Science Group Limited , Acarbose Tablets , Drug Application , Drug Inspections , Uni Bio Science , Blowing Filling , Diquafosol Sodium Eye Drops , Alephoson Biopharmaceuticals , Cell Penetration Protein Alternation Technology , Bio Science Group Limited ,